Jackson Memorial Hospital/University of Miami
Welcome,         Profile    Billing    Logout  
 11 Trials 
22 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Goldberg, David
ADapt, NCT05369403: A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab

Active, not recruiting
3
120
US
Lebrikizumab, LY3650150, DRM06
Eli Lilly and Company
Atopic Dermatitis
01/24
02/25
PLATyPuS, NCT02315898: Inhaled Tissue Plasminogen Activator for Acute Plastic Bronchitis

Completed
2
40
US
Treatment-inhaled tPA, alteplase, Activase
University of Michigan, Genentech, Inc.
Plastic Bronchitis, Protein-Losing Enteropathies, Healthy
03/21
06/23
NCT04844840: A Study for Safety and Efficacy Evaluation of Various Doses of STP705 in Reducing Keloid Recurrence

Completed
2
29
US
STP705, STP705 Powder for Injection, Placebo
Sirnaomics
Keloid
05/23
05/23
NCT04844983: A Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Patients With isSCC

Completed
2
44
US
STP705, STP705 Powder for Injection, Placebo Saline
Sirnaomics
Squamous Cell Carcinoma in Situ
08/22
12/22
NCT06176768: A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis

Recruiting
2
75
US
LY3972406, Placebo
Eli Lilly and Company
Plaque Psoriasis
04/25
07/25
THINKER-NEXT, NCT04075916: A Trial of Transplanting Hepatitis C Kidneys Into Hepatitis C-Negative Kidney Recipients

Active, not recruiting
2
201
US
Epclusa
University of Pennsylvania, Gilead Sciences, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
End Stage Renal Disease
06/25
01/26
LCN RESCU, NCT05832229: Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

Recruiting
2
256
US
Rosuvastatin, Rosuvastatin 20 mg, Rosuvastatin 10 mg
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), The Cleveland Clinic, Columbia University, Weill Medical College of Cornell University, Duke University, Mayo Clinic, University of Miami, University of Michigan, University of California, San Diego, University of California, San Francisco, LAC+USC Medical Center, Virginia Commonwealth University, National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Cancer Institute (NCI), University of Southern California
Cirrhosis, Cirrhosis, Liver, Cirrhosis Early, Cirrhosis Due to Hepatitis B, Cirrhosis Advanced, Cirrhosis Infectious, Cirrhosis Alcoholic, Cirrhosis Due to Hepatitis C
11/26
11/26
FALD, NCT03430583: Evaluation of Fontan-Associated Liver Disease

Active, not recruiting
N/A
100
Canada, US
MZ101
Mezzion Pharma Co. Ltd, National Heart, Lung, and Blood Institute (NHLBI)
Single Ventricle Heart Disease
06/21
08/21
RELAX, NCT05457322: The Trial: Nonpharmaceutical Intervention for Nocturnal Muscle Cramps

Completed
N/A
99
US
Behavioral intervention one, Behavioral intervention two
University of Michigan
Cramps, Muscle Cramp
08/23
08/23
NCT05358860: Safety and Efficacy of Sofwave Treatment for Acne Scars Appearance Improvement

Completed
N/A
60
US
Sofwave, SUPERB
Sofwave Medical LTD
Acne Scars - Mixed Atrophic and Hypertrophic
12/22
12/22
NCT05882721: Treatment for Improvement of Cellulite Appearance Using Form Applicator

Completed
N/A
60
US
Sofwave
Sofwave Medical LTD
Cellulite
11/23
11/23
NCT05323253: A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma

Recruiting
N/A
86
Canada, US, RoW
DaRT seeds, DaRT
Alpha Tau Medical LTD.
Recurrent Squamous Cell Carcinoma
12/24
12/25
TEST, NCT05260268: Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant

Recruiting
N/A
360
US
TEST Intervention
University of Pennsylvania, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Liver Transplant; Complications, Cirrhosis, End Stage Liver DIsease, Medication Adherence
07/26
01/27
LCN-C, NCT05740358: Liver Cirrhosis Network Cohort Study

Recruiting
N/A
1200
US
Northwestern University, The Cleveland Clinic, Columbia University, Weill Medical College of Cornell University, Duke University, Mayo Clinic, University of Miami, University of Michigan, University of California, San Diego, University of California, San Francisco, LAC+USC Medical Center, Virginia Commonwealth University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Cancer Institute (NCI), University of Southern California, Central Virginia Veterans Healthcare System
Cirrhosis, Cirrhosis, Liver, Cirrhosis Early, Cirrhosis Due to Hepatitis B, Cirrhosis Advanced, Cirrhosis Infectious, Cirrhosis Alcoholic, Cirrhosis, Biliary, Cirrhosis Cryptogenic, Cirrhosis Due to Hepatitis C, Cirrhosis Due to Primary Sclerosing Cholangitis
09/27
09/28
Zarrinpar, Ali
ICG, NCT04942665: Low Dose for Biliary Tract and Tumor Imaging

Completed
2
60
US
Indocyanine green, ICG, PINPOINT Endoscopic Fluorescence, NIRF
University of Florida, Society of University Surgeons
Cholecystitis, Hepatocellular Carcinoma, Liver Metastases
09/22
04/23
I-SPY_COVID, NCT04488081: I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients

Recruiting
2
1500
US
Remdesivir, GS-5734, Imatinib Mesylate, Dexamethasone, Cenicriviroc, Icatibant, Firazyr, Apremilast, Otezla, dornase alfa, Pulmozyme, Celecoxib, celebrex, Famotidine, Pepcid, IC14, Aviptadil, Zyesami, narsoplimab, OMS721, Cyproheptadine, periactin, Cyclosporine, CsA
QuantumLeap Healthcare Collaborative, University of California, San Francisco, University of Pennsylvania, Emory University, University of Alabama at Birmingham, University of Colorado, Denver, University of Southern California, Yale University, Wake Forest University Health Sciences, Sanford Health, Long Beach Memorial Medical Center, Georgetown University, University of California, Davis, Hoag Memorial Hospital Presbyterian, Main Line Health, DHR Health Institute for Research and Development, University of California, Irvine, Corewell Health, Kaiser Permanente, University of Michigan, West Virginia University, University of Miami, University Hospitals Cleveland Medical Center, Virtua Health, M.D. Anderson Cancer Center
COVID-19
07/28
07/30
THINKER-NEXT, NCT04075916: A Trial of Transplanting Hepatitis C Kidneys Into Hepatitis C-Negative Kidney Recipients

Active, not recruiting
2
201
US
Epclusa
University of Pennsylvania, Gilead Sciences, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
End Stage Renal Disease
06/25
01/26
NCT06217094: Study of NP-101 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Undergoing Y-90 Treatment

Not yet recruiting
1
18
US
NP-101 (3 g), NP-101 (4.8 g), NP-101 (6 g)
University of Florida, Novatek, Florida Department of Health
Hepatocellular Carcinoma
07/26
09/29
UF-GI-015, NCT05669339: AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma

Recruiting
1
12
US
Irinotecan, Sonidegib, Sorafenib
University of Florida, Sun Pharmaceutical Industries Ltd
Hepatocellular Carcinoma
04/26
04/26
AIIM, NCT05432765: Trial: Personalized Medicine Approach to Kidney Allograft Function

Not yet recruiting
N/A
34
US
Phenotypic Personalized Medicine Dosing, Standard of Care Dosing
University of Florida
Kidney Transplant Rejection
08/25
01/26
TGI, NCT06063213: Using Transcriptional Assessment of Immune Response to Assess Immunosuppression After Liver Transplantation

Recruiting
N/A
40
US
University of Florida, Transplant Genomics, Inc.
Transplant Complication
10/25
10/25
ProActive, NCT04091984: The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry

Active, not recruiting
N/A
5000
US
Prospera
Natera, Inc., University of Maryland
Kidney Transplant Rejection
10/26
10/27

Download Options